Successful Management of Severe Bleeding After Redo Cardiac Transplantation With Recombinant Activated Factor VII

Journal of Clinical Case Reports

doi 10.4172/scientificreports.225

Full Text

Abstract

Available in

Date

Authors

Publisher

OMICS Publishing Group

Related search

Recombinant Activated Factor VII (rFVIIa) Treatment of Refractory Bleeding in Cardiac Surgical Patients

Journal of Anesthesia & Clinical Research
2012English

Successful Management Preventing Severe Bleeding During the Perioperative Period for Subdural Hematoma by Using Recombinant Activated Coagulation Factor VII in a Case of Acquired Hemophilia A

Kitakanto Medical Journal
Medicine
2016English

The Use of Recombinant Activated Factor VII for Refractory Bleeding Post Complex Cardiothoracic Surgery

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2006English

Redo Cardiac Surgery: Bleeding Control

World Journal of Cardiovascular Diseases
2017Spanish

Recombinant Activated Factor VII and Aortic Surgery

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2013English

Successful Use of Recombinant Activated Factor VII for Postoperative Associated Haemorrhage: A Case Report

Cases Journal
2008English

Effect of Recombinant Activated Factor VII in Critical Bleeding: Clinical Experience of a Single Center

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2009English

Use of Recombinant Factor VII in Cardiac Surgery

Recent Patents on Cardiovascular Drug Discovery
2012English

Letter by Al-Ruzzeh and Navia Regarding Article, "Safety and Efficacy of Recombinant Activated Factor VII: A Randomized Placebo-Controlled Trial in the Setting of Bleeding After Cardiac Surgery"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy